http://www.w3.org/ns/prov#value | - technology to be developed by PharMida is very promising and I have no doubt will prove to be of great importance to the development better therapeutic applications for patients in need, added Professor Fritz R. Buhler, Chairman.####About Midatech GroupMidatech Group Ltd, UK, is a world leader in the design, synthesis and manufacture of biocompatible nanoparticles.
|